Vertex Lifts These Biotech ETFs

Shares of Vertex Pharmaceuticals (NasdaqGS: VRTX) surged more than 42% Tuesday on volume that is already 11 times above the daily average after the company said two Phase III trials for its cystic fibrosis treatment showed encouraging results. Analysts doubted the ability of Vertex to combine...